Skip to main navigation Skip to search Skip to main content

In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists

  • R.A. Bakker
  • , M.W. Nicholas
  • , T.F. Smith
  • , E.S. Burstein
  • , U. Hacksell
  • , H. Timmerman
  • , R. Leurs
  • , M.R. Brann
  • , D.M. Weiner

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

The human histamine H
Original languageEnglish
Pages (from-to)172-9
JournalThe Journal of Pharmacology and Experimental Therapeutics
Volume322
Issue number1
DOIs
Publication statusPublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists'. Together they form a unique fingerprint.

Cite this